Skip to search formSkip to main contentSkip to account menu

Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… 
National Institutes of Health

Related topics

Related topics

1 relation
Vaccines, Conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Vaccination Rates among Adolescents in Minnesota as Compared with the United States: Not "Above Average".
Because adolescents make relatively few visits to clinics for preventive care, their vaccination rates suffer. We examined rates… 
Review
2014
Review
2014
Adolescent vaccination in Oklahoma: a work in progress.
BACKGROUND Nationally, uptake of adolescent vaccines is variable. OBJECTIVE To compare adolescent immunization rates and… 
2011
2011
Les vaccins contre le méningocoque au Canada : une mise à jour
Resume L’infection par le meningocoque est grave, car elle est souvent responsable d’une septicemie ou d’une meningite… 
2009
2009
A new meningococcal conjugate vaccine: What should physicians know and do?
A quadrivalent meningococcal conjugate vaccine for serogroups A, C, Y and W135 (MCV4 [Menactra, sanofi pasteur, Canada]) was… 
2007
2007
Recommendations updated for PCV7, MCV4 vaccines
When pneumococcal conjugate vaccine (PCV7) was licensed,“ catch-up” doses were recommended only for 24- to 59-month-old children… 
Review
2007
Review
2007
National Survey Assessing Pediatricians Adoption of New Tdap (Adacel/Boostrix) and MCV4 (Menactra) Vaccines for Adolescents
2006
2006
Inadvertent misadministration of meningococcal conjugate vaccine--United States, June-August 2005.
  • MMWR. Morbidity and mortality weekly report
  • 2006
  • Corpus ID: 23312301
During June-August 2005, CDC and the Food and Drug Administration (FDA) were notified of seven clusters of inadvertent… 
2005
2005
Infectious Diseases Prevention and Control of Meningococcal Disease : Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
  • 2005
  • Corpus ID: 261969817
Two peaks in the incidence of invasive meningococcal disease (IMD) occur in pediatric patients: infants younger than 1 year and… 
2005
2005
Meningitis vaccine recommended for three groups of young people
The US Centers for Disease Control and Prevention (CDC) has recommended the use of a new vaccine against meningitis for three… 
2005
2005
ACIP recommends meningococcal vaccine: Targeted groups include those 11-12 years, 15 years and college freshmen in dormitories
The newly licensed meningococcal conjugate vaccine (MCV4, Menactra) now is recommended for adolescents and college students, a…